{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T20:24:44Z","timestamp":1777926284471,"version":"3.51.4"},"reference-count":50,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T00:00:00Z","timestamp":1713312000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Research Foundation of Korea (NRF)","award":["RS-2023-00219725"],"award-info":[{"award-number":["RS-2023-00219725"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background\/Objectives: Diabetic foot ulcers are one of the complications in patients with diabetes, which can be caused by infection, neuropathy, and blood vessel disorder. Among them, infection is the most common cause, and if it becomes worse, amputation may be necessary. So, it is important to detect and treat infections early, and determining indicators that can confirm infection is also important. Known infection markers include white blood cells (WBCs), the erythrocyte sediment rate (ESR), C-reactive protein (CRP), and procalcitonin, but they are not specific to diabetic foot ulcers. Presepsin, also known as soluble CD14, is known to be an early indicator of sepsis. Recent studies have reported that presepsin can be used as an early indicator of infection. This study investigated whether presepsin could be used as an early marker of severe infection in patients with diabetic foot ulcers. Methods: We retrospectively studied 73 patients who were treated for diabetic foot ulcerations from January 2021 to June 2023 at Yeungnam University Hospital. Results: Out of a total of 73 patients, 46 patients underwent amputations with severe infections, and the WBC level, ESR, and CRP, procalcitonin, and presepsin levels were significantly higher in the group of patients who underwent amputations. The cutoff of presepsin, which can predict serious infections that need amputation, was 675 ng\/mL. A regression analysis confirmed that presepsin, HbA1c, and osteomyelitis significantly increased the risk of severe infections requiring amputation. Conclusions: Presepsin will be available as an early predictor of patients with severe infections requiring amputations for diabetic foot ulcerations.<\/jats:p>","DOI":"10.3390\/jcm13082311","type":"journal-article","created":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T07:54:36Z","timestamp":1713340476000},"page":"2311","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The Potential Role of Presepsin in Predicting Severe Infection in Patients with Diabetic Foot Ulcers"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9534-4329","authenticated-orcid":false,"given":"Eun Yeong","family":"Ha","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Yeungnam University Medical Center, Daegu 42415, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Il Rae","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yeungnam University Medical Center, Daegu 42415, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3336-7557","authenticated-orcid":false,"given":"Seung Min","family":"Chung","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yeungnam University Medical Center, Daegu 42415, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Nam","family":"Roh","sequence":"additional","affiliation":[{"name":"Department of Surgery, Yeungnam University Medical Center, Daegu 42415, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chul Hyun","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, Yeungnam University Medical Center, Daegu 42415, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae-Gon","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Plastic Surgery, Yeungnam University Medical Center, Daegu 42415, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Woong","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yeungnam University Medical Center, Daegu 42415, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1569-3068","authenticated-orcid":false,"given":"Jun Sung","family":"Moon","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yeungnam University Medical Center, Daegu 42415, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,4,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"American Diabetes Association (2009). Diagnosis and classification of diabetes mellitus. Diabetes Care, 32, S62\u2013S67.","DOI":"10.2337\/dc09-S062"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.2337\/dc24-SINT","article-title":"Introduction and Methodology: Standards of Care in Diabetes\u20142024","volume":"47","author":"Elsayed","year":"2024","journal-title":"Diabetes Care"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.2337\/dc23-ad09","article-title":"Addendum. 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes\u20142023. Diabetes Care 2023;46(Suppl. 1):S49\u2013S67","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"417","DOI":"10.4093\/dmj.2022.0106","article-title":"Diabetes Fact Sheet in Korea 2021","volume":"46","author":"Bae","year":"2022","journal-title":"Diabetes Metab. J."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.biopha.2018.07.157","article-title":"Chronic hyperglycemia mediated physiological alteration and metabolic distortion leads to organ dysfunction, infection, cancer progression and other pathophysiological consequences: An update on glucose toxicity","volume":"107","author":"Giri","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2337\/dci22-0043","article-title":"Etiology, Epidemiology, and Disparities in the Burden of Diabetic Foot Ulcers","volume":"46","author":"McDermott","year":"2023","journal-title":"Diabetes Care"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jtv.2022.05.001","article-title":"C-reactive protein and diabetic foot ulcer infections: A meta-analysis","volume":"31","author":"Zhang","year":"2022","journal-title":"J. Tissue Viability"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00125-007-0840-8","article-title":"Serum procalcitonin and C-reactive protein concentrations to distinguish mildly infected from non-infected diabetic foot ulcers: A pilot study","volume":"51","author":"Jeandrot","year":"2008","journal-title":"Diabetologia"},{"key":"ref_9","first-page":"1395","article-title":"Role of presepsin for the evaluation of sepsis in the emergency department","volume":"52","author":"Pizzolato","year":"2014","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4103\/jrms.JRMS_906_16","article-title":"Procalcitonin levels and other biochemical parameters in patients with or without diabetic foot complications","volume":"22","author":"Abu","year":"2017","journal-title":"J. Res. Med. Sci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.jvs.2017.02.060","article-title":"Potential of circulatory procalcitonin as a biomarker reflecting inflammation among South Indian diabetic foot ulcers","volume":"67","author":"Umapathy","year":"2018","journal-title":"J. Vasc. Surg."},{"key":"ref_12","first-page":"3","article-title":"Procalcitonin as a diagnostic and prognostic marker in diabetic foot infection. A current literature review","volume":"56","author":"Velissaris","year":"2018","journal-title":"Rom. J. Intern. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"117588","DOI":"10.1016\/j.cca.2023.117588","article-title":"Presepsin in the diagnosis of sepsis","volume":"550","author":"Paraskevas","year":"2023","journal-title":"Clin. Chim. Acta"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"117","DOI":"10.5005\/jp-journals-10071-23741","article-title":"Presepsin: A Promising Biomarker for Sepsis","volume":"25","author":"Azim","year":"2021","journal-title":"Indian. J. Crit. Care Med."},{"key":"ref_15","first-page":"e15019","article-title":"Presepsin as a Diagnostic and Prognostic Biomarker in Sepsis","volume":"13","author":"Velissaris","year":"2021","journal-title":"Cureus"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijid.2020.03.057","article-title":"Presepsin values as markers of severity of sepsis","volume":"95","author":"Atelj","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"R244","DOI":"10.1186\/cc13070","article-title":"Diagnostic value and prognostic evaluation of Presepsin for sepsis in an emergency department","volume":"17","author":"Liu","year":"2013","journal-title":"Crit. Care"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Piccioni, A., Santoro, M.C., de Cunzo, T., Tullo, G., Cicchinelli, S., Saviano, A., Valletta, F., Pascale, M.M., Candelli, M., and Covino, M. (2021). Presepsin as Early Marker of Sepsis in Emergency Department: A Narrative Review. Medicina, 57.","DOI":"10.3390\/medicina57080770"},{"key":"ref_19","first-page":"11","article-title":"Presepsin vs Procalcitonin as Predictors of Sepsis Outcome","volume":"70","author":"Narendra","year":"2022","journal-title":"J. Assoc. Physicians India"},{"key":"ref_20","first-page":"62","article-title":"Usefulness of Presepsin Measurement: A New Biomarker for Sepsis","volume":"63","author":"Okamura","year":"2015","journal-title":"Rinsho Byori"},{"key":"ref_21","first-page":"93","article-title":"Presepsin (sCD14-ST) secretion and kinetics by peripheral blood mononuclear cells and monocytic THP-1 cell line","volume":"74","author":"Bardet","year":"2016","journal-title":"Ann. Biol. Clin."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group","volume":"130","author":"Levey","year":"1999","journal-title":"Ann. Intern. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"398","DOI":"10.4093\/dmj.2019.0137","article-title":"2019 Clinical Practice Guidelines for Type 2 Diabetes Mellitus in Korea","volume":"43","author":"Cappon","year":"2019","journal-title":"Diabetes Metab J."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"855","DOI":"10.2337\/diacare.21.5.855","article-title":"Validation of a diabetic wound classification system. The contribution of depth, infection, and ischemia to risk of amputation","volume":"21","author":"Armstrong","year":"1998","journal-title":"Diabetes Care"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1177\/1526602820966309","article-title":"A Novel Scoring System for Small Artery Disease and Medial Arterial Calcification Is Strongly Associated With Major Adverse Limb Events in Patients With Chronic Limb-Threatening Ischemia","volume":"28","author":"Ferraresi","year":"2021","journal-title":"J. Endovasc. Ther."},{"key":"ref_27","unstructured":"Yeom, J.G. (2021). PATHFAST Presepsin, Asanpharm."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/iwj.12536","article-title":"The role of procalcitonin as a marker of diabetic foot ulcer infection","volume":"14","author":"Massara","year":"2017","journal-title":"Int. Wound J."},{"key":"ref_29","first-page":"113","article-title":"Diabetic foot osteomyelitis: Usefulness of erythrocyte sedimentation rate in its diagnosis","volume":"26","author":"Malabu","year":"2007","journal-title":"West Afr. J. Med."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Arag\u00f3n-S\u00e1nchez, J., V\u00edquez-Molina, G., L\u00f3pez-Valverde, M.E., and Rojas-Bonilla, J.M. (2023). Systemic Immune-Inflammation Index in Diabetic Foot Infections and Osteomyelitis. Int. J. Low. Extrem. Wounds, online ahead of print.","DOI":"10.1177\/15347346231179280"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.21037\/jtd.2019.12.63","article-title":"The complete blood count to diagnose septic shock","volume":"12","author":"Farkas","year":"2020","journal-title":"J. Thorac. Dis."},{"key":"ref_32","first-page":"7","article-title":"Biomarkers for Sepsis: What Is and What Might Be?","volume":"10","author":"Biron","year":"2015","journal-title":"Biomark. Insights"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Lee, S., Song, J., Park, D.W., Seok, H., Ahn, S., Kim, J., Park, J., Cho, H.J., and Moon, S. (2022). Diagnostic and prognostic value of presepsin and procalcitonin in non-infectious organ failure, sepsis, and septic shock: A prospective observational study according to the Sepsis-3 definitions. BMC Infect. Dis., 22.","DOI":"10.1186\/s12879-021-07012-8"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"527","DOI":"10.4266\/acc.2022.00150","article-title":"Validation of presepsin measurement for mortality prediction of sepsis: A preliminary study","volume":"37","author":"Baik","year":"2022","journal-title":"Acute Crit. Care"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Chen, M., and Zhu, Y. (2020). Utility of sTREM-1 and Presepsin (sCD14-ST) as Diagnostic and Prognostic Markers of Sepsis. Clin. Lab., 66.","DOI":"10.7754\/Clin.Lab.2019.190508"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s10156-012-0435-2","article-title":"Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study","volume":"18","author":"Endo","year":"2012","journal-title":"J. Infect. Chemother."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"153","DOI":"10.5005\/jp-journals-10071-23715","article-title":"Role of Presepsin for the Diagnosis of Sepsis and ICU Mortality: A Prospective Controlled Study","volume":"25","author":"Abdelshafey","year":"2021","journal-title":"Indian J. Crit. Care Med."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Park, J.E., Lee, B., Yoon, S.J., Park, C.M., Jung, C.W., Ahn, M.J., Park, H.D., Hwang, S.Y., Shin, T.G., and Kang, E.S. (2021). Complementary Use of Presepsin with the Sepsis-3 Criteria Improved Identification of High-Risk Patients with Suspected Sepsis. Biomedicines, 9.","DOI":"10.21203\/rs.3.rs-659486\/v1"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s10238-022-00936-8","article-title":"Presepsin levels and COVID-19 severity: A systematic review and meta-analysis","volume":"23","author":"Guarino","year":"2023","journal-title":"Clin. Exp. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00590-022-03232-z","article-title":"Presepsin as a diagnostic biomarker of peri-prosthetic joint infection: A review of the literature","volume":"33","author":"Delva","year":"2023","journal-title":"Eur. J. Orthop. Surg. Traumatol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"9914927","DOI":"10.1155\/2022\/9914927","article-title":"Presepsin Predicts Severity and Secondary Bacterial Infection in COVID-19 by Bioinformatics Analysis","volume":"2022","author":"Chang","year":"2022","journal-title":"Comput. Math. Methods Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"9857","DOI":"10.12998\/wjcc.v9.i32.9857","article-title":"Presepsin as a biomarker for risk stratification for acute cholangitis in emergency department: A single-center study","volume":"9","author":"Zhang","year":"2021","journal-title":"World J. Clin. Cases"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1111\/1756-185X.12899","article-title":"Presepsin and procalcitonin as biomarkers of systemic bacterial infection in patients with rheumatoid arthritis","volume":"21","author":"Tsujimoto","year":"2018","journal-title":"Int. J. Rheum. Dis."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Igna, R., G\u00eerleanu, I., Cojocariu, C., Huiban, L., Muz\u00eeca, C., S\u00eengeap, A.M., Sfarti, C., Chiriac, S., Petrea, O.C., and Zenovia, S. (2022). The Role of Presepsin and Procalcitonin in Early Diagnosis of Bacterial Infections in Cirrhotic Patients with Acute-on-Chronic Liver Failure. J. Clin. Med., 11.","DOI":"10.3390\/jcm11185410"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.cca.2017.12.045","article-title":"Presepsin as a novel diagnostic biomarker for differentiating active pulmonary tuberculosis from bacterial community acquired pneumonia","volume":"478","author":"Qi","year":"2018","journal-title":"Clin. Chim. Acta"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s41100-017-0113-z","article-title":"Presepsin is a potent biomarker for diagnosing skin wound infection in hemodialysis patients compared to white blood cell count, high-sensitivity C-reactive protein, procalcitonin, and soluble CD14","volume":"3","author":"Shiota","year":"2017","journal-title":"Ren. Replace. Ther."},{"key":"ref_47","first-page":"578","article-title":"Predictive Value of Soluble CD14, Interleukin-6 and Procalcitonin For Lower Extremity Amputation in People with Diabetes with Foot Ulcers: A Pilot Study","volume":"30","author":"Karakas","year":"2014","journal-title":"Pak. J. Med. Sci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.cca.2013.09.019","article-title":"Presepsin (sCD14-ST) in emergency department: The need for adapted threshold values?","volume":"427","author":"Trabattoni","year":"2014","journal-title":"Clin. Chim. Acta"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Arakawa, K., Saeki, A., Ide, R., and Matsushita, Y. (2022). Presepsin cut-off value for diagnosis of sepsis in patients with renal dysfunction. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0273930"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Lin, C., Liu, J., and Sun, H. (2020). Risk factors for lower extremity amputation in patients with diabetic foot ulcers: A meta-analysis. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0239236"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/8\/2311\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:29:03Z","timestamp":1760106543000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/8\/2311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,17]]},"references-count":50,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,4]]}},"alternative-id":["jcm13082311"],"URL":"https:\/\/doi.org\/10.3390\/jcm13082311","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,17]]}}}